News Category
Quantum BioPharma's FDA clearance to advance Lucid-MS into Phase 2 trials marks a significant step toward a novel neuroprotective therapy for multiple...
PX1 Research's new seven-stage HPLC purity verification and cGMP compliance across its US-based peptide manufacturing ensures batch-level documentatio...
NanoViricides received regulatory approval to begin a Phase II trial of its oral antiviral NV-387 in the Democratic Republic of Congo, potentially off...
Peer-reviewed data demonstrate Telomir-Zn's selective anti-tumor activity in TNBC models, supporting advancement to Phase 1/2 clinical trials.
The FDA's approval of Quantum BioPharma's IND application for Lucid-MS advances a novel neuroprotective candidate targeting demyelination into Phase 2...
Tonix Pharmaceuticals' second-quarter revenue surged to $13.5 million, propelled by TONMYA's robust sales, signaling strong commercial uptake and a pr...
Tonix Pharmaceuticals' Q2 2026 revenue surged to $13.5 million, fueled by $11 million in TONMYA sales, while the company progresses its clinical pipel...
Regentis Biomaterials is progressing its GelrinC cartilage regeneration technology through clinical trials and regulatory approvals, positioning it as...
Quantum BioPharma's two-pronged approach, combining its MS therapy Lucid-MS and supplement unbuzzd, highlights a novel strategy that could reshape tre...
Quantum BioPharma's two-pronged approach targets multiple sclerosis through Lucid-MS and alcohol misuse with unbuzzd, potentially offering new therape...
VERAXA Biotech's proprietary BiTAC platform and pipeline of bispecific ADCs and T-cell engagers position it to capitalize on significant pharmaceutica...
A case in Spain where a patient's pork tapeworm infection mimicked brain cancer underscores the dangers of undercooked pork and the need for better di...
VERAXA Biotech has advanced its VXA-222 bispecific antibody-drug conjugate into the next development stage and expanded its patent portfolio, strength...
A new liquid biopsy offers a simpler way to forecast which advanced lung cancer patients will benefit from immunotherapy, potentially aiding drug deve...
GeoVax's completion of manufacturing, regulatory, and preclinical milestones for its GEO-MVA mpox/smallpox vaccine de-risks the program and paves the ...
Onco-Innovations is leveraging a multi-pronged approach combining PNKP-targeted DDR inhibition, nanoparticle delivery, and AI to advance its lead cand...
Nagoya University researchers discovered that the immune protein C3, when produced by tumor cells, can boost the effectiveness of immunotherapy, offer...
VolitionRx's new Capture-Seq technology isolates pure ctDNA, addressing a major challenge in liquid biopsy and opening doors to multi-cancer early det...
Tonix Pharmaceuticals announced participation in two key investor conferences, providing a platform to discuss its commercial progress and pipeline, w...
VERAXA Biotech's VXA-222 bispecific antibody-drug conjugate advances to the next development stage, supported by an expanded patent portfolio, undersc...
NeuroThera Labs has initiated its Phase IIb clinical trial for SCI-110 at the Yale Child Study Center, marking a significant step in developing a nove...
SRX Global acquires a stake in Vistagen Therapeutics, signaling confidence in the undervalued biopharmaceutical company and potential strategic initia...
SRX Global's acquisition of a stake in Vistagen Therapeutics signals confidence in the undervalued biopharmaceutical company and potential for strateg...
Quantum BioPharma reports encouraging preliminary PET imaging data from its MS study with Massachusetts General Hospital, supporting the potential of ...
Biotech Labz Supply Inc now offers 11 documented research peptides, including BPC-157 and Tesamorelin, each with batch-specific certificates of analys...
Oncotelic Therapeutics will present at the OTCQB Virtual Investor Conference, showcasing advancements in its Phase 1b Everolimus trial, Deciparticle p...
Tonix Pharmaceuticals announced FDA feedback supporting its adaptive Phase 2 field study of TNX-4800, a long-acting monoclonal antibody for Lyme disea...
Recent independent findings suggest that licensed Ebola vaccines may induce cross-reactive immune responses to related viruses, underscoring the value...
Regentis Biomaterials' GelrinC offers a practical, off-the-shelf solution for cartilage repair, addressing a significant unmet need in orthopedics.
Quantum BioPharma's halfway-point enrollment in an MS imaging study with Massachusetts General Hospital yields encouraging preliminary PET data, poten...
NeuroThera Labs has demonstrated a complete hybrid quantum-classical workflow for processing real-world clinical data, marking a significant step towa...
NeuroOne released a white paper detailing how its StereoCED™ platform, leveraging robotic stereotactic systems, aims to overcome procedural bottleneck...
VERAXA Biotech has promoted Dr. Christoph Erkel to Chief Scientific Officer to lead the development of its BiTAC platform and oncology pipeline, follo...
Onco-Innovations Limited closed a CAD$5 million private placement with Sorbie entities, funding the advancement of its ONC010 program and SynoGraph pl...
Lexaria Bioscience Corp. will effect a 1-for-15 reverse stock split effective August 3, 2026, to increase its share price and regain compliance with N...
VolitionRx announced a growing body of clinical evidence supporting its Nu.Q NETs assay as a biomarker for sepsis, with studies showing it can disting...
Instinct Bio announced a strategic collaboration with INVITRX to manufacture and sell GENREVER cosmetics in the U.S. and supply exosomes for Indonesia...
Renaissance BioScience Corp. appoints Dr. James Tansey, a serial entrepreneur and professor at UBC, to its board, leveraging his expertise in technolo...
Dr. Sven K. Weber will become CEO of BRAIN Biotech AG on October 1, 2026, bringing extensive experience from BASF's global enzyme business to drive gr...
VERAXA Biotech announced the expansion of its intellectual property portfolio with new patent applications covering its BiTAC-TCE and BiTAC-ADC platfo...
MindBio Therapeutics has completed and delivered its first Edge AI intoxication and fatigue detection kiosks, aiming to provide rapid, scalable, and l...
VERAXA Biotech appoints Dr. Christoph Erkel as Chief Scientific Officer to lead its proprietary BiTAC(R) technology platform toward clinical developme...
VERAXA Biotech AG has filed new patent applications for its BiTAC-TCE and BiTAC-ADC platforms, expanding its IP portfolio to over 50 granted patents a...
Greenland Mines obtained a Canadian patent for Klotho-based gene therapies targeting neurodegenerative diseases, expanding its IP portfolio and advanc...
Quantum BioPharma (NASDAQ: QNTM) is advancing its lead multiple sclerosis drug candidate Lucid-MS into Phase 2 clinical trials while generating revenu...
VERAXA Biotech shareholders approved corporate governance and financing proposals with over 99.94% support, enabling greater flexibility for growth an...
Greenland Mines Ltd. announced a Canadian patent for its Klotho-based gene therapy technology, expanding its IP portfolio and advancing treatments for...
NanoViricides has submitted an application to begin a Phase II trial of its oral antiviral NV-387 for Bundibugyo ebolavirus in the DRC, where no appro...
